DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
ARASERTACONAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Candidiasis, Vulvovaginal
Unknown
ARASERTACONAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
PR82C5R514
Molecule Type:
Small molecule
Molecular Formula:
C20H15Cl3N2OS
Molecular Weight:
437.78
AlogP:
7.02
PSA:
27.05
HBD:
0.0
HBA:
#RotB:
6.0
Source:
1018 ISS
2
Unknown
Investigational
Unknown
Unknown
Colorectal Neoplasms; HIV Infections; Hepatitis B, Chronic; Lymphoma, Non-Hodgkin; Severe Acute Respiratory Syndrome
Toll-like receptor 9 agonist
1018 ISS
×
Maximum Phase:
2
First Approval:
None
UNII:
25DT549L0G
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY2624803
2
Small molecule
Investigational
Unknown
Unknown
Sleep Initiation and Maintenance Disorders
Histamine H1 receptor antagonist
LY2624803
×
Maximum Phase:
2
First Approval:
None
UNII:
63J9EQ81YC
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAURODEOXYCHOLIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Sepsis; Dermatitis, Atopic
Unknown
TAURODEOXYCHOLIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
20668G0RPI
Molecule Type:
Small molecule
Molecular Formula:
C26H45NO6S
Molecular Weight:
499.71
AlogP:
3.4
PSA:
123.93
HBD:
4.0
HBA:
#RotB:
7.0
Source:
PULRODEMSTAT BESILATE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia; Lymphoma, Non-Hodgkin; Prostatic Neoplasms; Small Cell Lung Carcinoma; Neoplasms
Unknown
PULRODEMSTAT BESILATE
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C30H29F2N5O5S
Molecular Weight:
609.66
AlogP:
3.2
PSA:
97.17
HBD:
1.0
HBA:
#RotB:
4.0
Source:
IMR-687
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IMR-687
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ACT-709478
2
Small molecule
Investigational
Unknown
Unknown
Epilepsy, Reflex
Voltage-gated T-type calcium channel blocker
ACT-709478
×
Maximum Phase:
2
First Approval:
None
UNII:
3Z7U1U8Z9E
Molecule Type:
Small molecule
Molecular Formula:
C22H18F3N5O
Molecular Weight:
425.41
AlogP:
3.97
PSA:
83.6
HBD:
1.0
HBA:
#RotB:
6.0
Source:
P276-00
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
P276-00
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CAPADENOSON
2
Small molecule
Investigational
Unknown
Unknown
Angina, Stable; Atrial Fibrillation
Adenosine A1 receptor partial agonist
CAPADENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
O519NVW73R
Molecule Type:
Small molecule
Molecular Formula:
C25H18ClN5O2S2
Molecular Weight:
520.04
AlogP:
5.51
PSA:
128.84
HBD:
2.0
HBA:
#RotB:
8.0
Source:
GLPG-0974
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Free fatty acid receptor 2 antagonist
GLPG-0974
×
Maximum Phase:
2
First Approval:
None
UNII:
X7REK61AIS
Molecule Type:
Small molecule
Molecular Formula:
C25H25ClN2O4S
Molecular Weight:
485.01
AlogP:
5.05
PSA:
77.92
HBD:
1.0
HBA:
#RotB:
8.0
Source:
HBM9161
2
Antibody
Investigational
Unknown
Unknown
Unknown
Unknown
HBM9161
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
QUETMOLIMAB
2
Antibody
Investigational
Unknown
Unknown
Arthritis, Rheumatoid; Crohn Disease; Liver Cirrhosis, Biliary
Fractalkine inhibitor
QUETMOLIMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
G8NT4Q571B
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BLX-028914
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BLX-028914
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
X
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
X
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBOCTADEKIN
2
Protein
Investigational
Unknown
Unknown
Lymphoma; Lymphoma, Non-Hodgkin; Neoplasms; Melanoma
Unknown
IBOCTADEKIN
×
Maximum Phase:
2
First Approval:
None
UNII:
X08H9UZ7TO
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CC-11050
2
Small molecule
Investigational
Unknown
Unknown
Lupus Erythematosus, Cutaneous; Tuberculosis
Phosphodiesterase 4 inhibitor
CC-11050
×
Maximum Phase:
2
First Approval:
None
UNII:
1Z08G7438A
Molecule Type:
Small molecule
Molecular Formula:
C24H28N2O6S
Molecular Weight:
472.56
AlogP:
3.18
PSA:
102.01
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AZD1305
2
Small molecule
Investigational
Unknown
Unknown
Atrial Fibrillation; Atrial Flutter
HERG blocker
AZD1305
×
Maximum Phase:
2
First Approval:
None
UNII:
CZO834LXQM
Molecule Type:
Small molecule
Molecular Formula:
C22H31FN4O4
Molecular Weight:
434.51
AlogP:
1.99
PSA:
87.06
HBD:
1.0
HBA:
#RotB:
7.0
Source:
AZD9150
2
Oligonucleotide
Investigational
Unknown
Unknown
Unknown
Unknown
AZD9150
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Oligonucleotide
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LANDOGROZUMAB
2
Antibody
Investigational
Unknown
Unknown
Neoplasms; Muscular Diseases; Pancreatic Neoplasms
Growth/differentiation factor 8 inhibitor
LANDOGROZUMAB
×
Maximum Phase:
2
First Approval:
None
UNII:
B1792M902R
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
EXEPORFINIUM
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EXEPORFINIUM
×
Maximum Phase:
2
First Approval:
None
UNII:
R41ECT47G6
Molecule Type:
Small molecule
Molecular Formula:
C44H50N6O2+2
Molecular Weight:
694.92
AlogP:
8.94
PSA:
75.82
HBD:
2.0
HBA:
#RotB:
12.0
Source:
C-1311
2
Small molecule
Investigational
Unknown
Unknown
Unknown
DNA topoisomerase II inhibitor
C-1311
×
Maximum Phase:
2
First Approval:
None
UNII:
MZ4Y5H4OAB
Molecule Type:
Small molecule
Molecular Formula:
C20H22N4O2
Molecular Weight:
350.42
AlogP:
2.9
PSA:
69.87
HBD:
2.0
HBA:
#RotB:
6.0
Source:
PEXACERFONT
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Anxiety Disorders; Irritable Bowel Syndrome
Corticotropin releasing factor receptor 1 antagonist
PEXACERFONT
×
Maximum Phase:
2
First Approval:
None
UNII:
LF1VBG4ZUK
Molecule Type:
Small molecule
Molecular Formula:
C18H24N6O
Molecular Weight:
340.43
AlogP:
3.33
PSA:
77.23
HBD:
1.0
HBA:
#RotB:
5.0
Source:
LAS100977
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LAS100977
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAS-109
2
Small molecule
Investigational
Unknown
Unknown
Colorectal Neoplasms
Unknown
TAS-109
×
Maximum Phase:
2
First Approval:
None
UNII:
00M634HD2V
Molecule Type:
Small molecule
Molecular Formula:
C10H12N4O4
Molecular Weight:
252.23
AlogP:
-1.78
PSA:
134.39
HBD:
3.0
HBA:
#RotB:
2.0
Source:
ILACIRNON
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerulosclerosis, Focal Segmental
C-C chemokine receptor type 2 antagonist
ILACIRNON
×
Maximum Phase:
2
First Approval:
None
UNII:
380F68J5PH
Molecule Type:
Small molecule
Molecular Formula:
C20H13ClF3N5O3S
Molecular Weight:
495.87
AlogP:
4.37
PSA:
117.7
HBD:
2.0
HBA:
#RotB:
5.0
Source:
AR-12286
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AR-12286
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BBV-152 ANTIGEN ADJUVATED WITH ALGEL-IMDG
2
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
BBV-152 ANTIGEN ADJUVATED WITH ALGEL-IMDG
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MT-3724
2
Unknown
Investigational
Unknown
Unknown
Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin
80S Ribosome inhibitor
MT-3724
×
Maximum Phase:
2
First Approval:
None
UNII:
R23ZRN6GWR
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NVN1000
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
NVN1000
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
ABX-1431
2
Small molecule
Investigational
Unknown
Unknown
Dyspepsia; Pain; Tourette Syndrome
Monoglyceride lipase inhibitor
ABX-1431
×
Maximum Phase:
2
First Approval:
None
UNII:
FB39E94UXK
Molecule Type:
Small molecule
Molecular Formula:
C20H22F9N3O2
Molecular Weight:
507.4
AlogP:
5.05
PSA:
36.02
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PIPERINE
2
Small molecule
Investigational
Unknown
Unknown
Deglutition Disorders; Pain
Unknown
PIPERINE
×
Maximum Phase:
2
First Approval:
None
UNII:
U71XL721QK
Molecule Type:
Small molecule
Molecular Formula:
C17H19NO3
Molecular Weight:
285.34
AlogP:
3.0
PSA:
38.77
HBD:
0.0
HBA:
#RotB:
3.0
Source:
3,5-DIIODOTHYROPROPIONIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia; Heart Failure
Unknown
3,5-DIIODOTHYROPROPIONIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
1HTO2X0SJ9
Molecule Type:
Small molecule
Molecular Formula:
C15H12I2O4
Molecular Weight:
510.07
AlogP:
4.41
PSA:
66.76
HBD:
2.0
HBA:
#RotB:
5.0
Source:
TOREFORANT TARTRATE
2
Small molecule
Investigational
Unknown
Unknown
Liver Diseases; Arthritis, Rheumatoid; Asthma; Psoriasis
Unknown
TOREFORANT TARTRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
HSV17TLD9C
Molecule Type:
Small molecule
Molecular Formula:
C50H70N12O6
Molecular Weight:
935.19
AlogP:
4.48
PSA:
69.73
HBD:
2.0
HBA:
#RotB:
6.0
Source:
AZD-8871
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-8871
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY3016859
2
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
LY3016859
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
132
133
134
135
136
137
138
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA